Skip to search.
 TSX Down 0.67% TSX Ventures Up 0.03%

Biogen Inc. (BIIB)

-NasdaqGS
312.58 Down 2.23(0.71%) Sep 23, 4:00PM EDT
|After Hours : 312.58 0.00 (0.00%) Sep 23, 6:02PM EDT
Prev Close:314.81
Open:312.58
Bid:311.00 x 100
Ask:319.00 x 100
1y Target Est:344.61
Beta:0.398444
Next Earnings Date:26-Oct-16BIIB Earnings announcement
Day's Range:312.11 - 317.32
52wk Range:223.02 - 333.65
Volume:881,641
Avg Vol (3m):1,828,500
Market Cap:68.49B
P/E (ttm):18.26
EPS (ttm):17.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBDown 0.71%68.49B
PFEUp 0.32%207.81B
ABTDown 0.07%62.02B

Key Statistics

Forward P/E (1 yr):15.00
P/S (ttm):6.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :20.10
Quarterly EPS Est (Sep-16) :5.01
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.83

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback